Loïc Van Dieren, Tom Quisenaerts, Mackenzie Licata, Arnaud Beddok, Alexandre G Lellouch, Dirk Ysebaert, Vera Saldien, Marc Peeters, Ivana Gorbaslieva
{"title":"Combined Radiotherapy and Hyperthermia: A Systematic Review of Immunological Synergies for Amplifying Radiation-Induced Abscopal Effects.","authors":"Loïc Van Dieren, Tom Quisenaerts, Mackenzie Licata, Arnaud Beddok, Alexandre G Lellouch, Dirk Ysebaert, Vera Saldien, Marc Peeters, Ivana Gorbaslieva","doi":"10.3390/cancers16213656","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The abscopal effect is a systemic immune response characterized by metastases regression at sites distant from the irradiated lesion. This systematic review aims to explore the immunological mechanisms of action underlying the abscopal effect and to investigate how hyperthermia (HT) can increase the chances of radiotherapy (RT) triggering systemic anti-tumor immune responses.</p><p><strong>Methods: </strong>This review is created in accordance with the PRISMA guidelines.</p><p><strong>Results and conclusion: </strong>HT and RT have both complementary and synergistic immunological effects. Both methods trigger danger signal release, promoting cytokine and chemokine secretion, which increases T-cell infiltration and facilitates cell death. Both treatments upregulate extracellular tumor HSP70, which could amplify DAMP recognition by macrophages and DCs, leading to stronger tumor antigen presentation and CTL-mediated immune responses. Additionally, the combined increase in cell adhesion molecules (VCAM-1, ICAM-1, E-selectin, L-selectin) could enhance leukocyte adhesion to tumors, improving lymphocyte trafficking and boosting systemic anti-tumor effects. Lastly, HT causes vasodilation and improves blood flow, which might exacerbate those distant effects. We suggest the combination of local radiotherapy with fever-range whole-body hyperthermia to optimally enhance the chances of triggering the abscopal effect mediated by the immune system.</p>","PeriodicalId":9681,"journal":{"name":"Cancers","volume":"16 21","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11545184/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancers","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/cancers16213656","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: The abscopal effect is a systemic immune response characterized by metastases regression at sites distant from the irradiated lesion. This systematic review aims to explore the immunological mechanisms of action underlying the abscopal effect and to investigate how hyperthermia (HT) can increase the chances of radiotherapy (RT) triggering systemic anti-tumor immune responses.
Methods: This review is created in accordance with the PRISMA guidelines.
Results and conclusion: HT and RT have both complementary and synergistic immunological effects. Both methods trigger danger signal release, promoting cytokine and chemokine secretion, which increases T-cell infiltration and facilitates cell death. Both treatments upregulate extracellular tumor HSP70, which could amplify DAMP recognition by macrophages and DCs, leading to stronger tumor antigen presentation and CTL-mediated immune responses. Additionally, the combined increase in cell adhesion molecules (VCAM-1, ICAM-1, E-selectin, L-selectin) could enhance leukocyte adhesion to tumors, improving lymphocyte trafficking and boosting systemic anti-tumor effects. Lastly, HT causes vasodilation and improves blood flow, which might exacerbate those distant effects. We suggest the combination of local radiotherapy with fever-range whole-body hyperthermia to optimally enhance the chances of triggering the abscopal effect mediated by the immune system.
简介缺席效应是一种全身性免疫反应,其特点是在远离照射病灶的部位出现转移消退。本系统性综述旨在探索缺席效应的免疫学作用机制,并研究热疗(HT)如何增加放疗(RT)引发全身抗肿瘤免疫反应的机会:本综述根据PRISMA指南撰写:热疗和放疗具有互补和协同的免疫效应。两种方法都会触发危险信号的释放,促进细胞因子和趋化因子的分泌,从而增加 T 细胞浸润并促进细胞死亡。这两种治疗方法都能上调细胞外肿瘤 HSP70,从而增强巨噬细胞和 DC 对 DAMP 的识别,导致更强的肿瘤抗原呈递和 CTL 介导的免疫反应。此外,细胞粘附分子(VCAM-1、ICAM-1、E-选择素、L-选择素)的联合增加可增强白细胞对肿瘤的粘附,改善淋巴细胞的迁移,增强全身抗肿瘤效应。最后,高温热疗会导致血管扩张,改善血流,这可能会加剧这些远处效应。我们建议将局部放疗与发热范围全身热疗相结合,以最大限度地提高免疫系统介导的脱灶效应的触发机会。
期刊介绍:
Cancers (ISSN 2072-6694) is an international, peer-reviewed open access journal on oncology. It publishes reviews, regular research papers and short communications. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.